Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: An approach for atherosclerosis imaging

Nanomedicine

Volumn 5, Issue 9, 2010, Pages 1341-1356

  Maiseyeu, Andrei ^a   Mihai, Georgeta ^a   Roy, Sashwati ^a,b   Kherada, Nisharahmed ^a   Simonetti, Orlando P ^a   Sen, Chandan K ^a,b   Sun, Qinghua ^a,b   Parthasarathy, Sampath ^a,b   Rajagopalan, Sanjay ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

atherosclerosis; low density lipoprotein; magnetic resonance imaging

Indexed keywords

CARBOXYLIC ACID; CHOLESTEROL 9 CARBOXYNONANOATE; CHOLESTEROL ESTER; FLUORESCENT DYE; GADOLINIUM; INTEGRIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLSERINE; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BIOCOMPATIBILITY; DISEASE COURSE; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; IMAGING SYSTEM; MACROPHAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RABBIT;

ANIMALS; ATHEROSCLEROSIS; CELLS, CULTURED; CHOLESTEROL ESTERS; CONTRAST MEDIA; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, LDL; LIPOSOMES; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MICROSCOPY, CONFOCAL; RABBITS;

EID: 78650074957     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.10.87     Document Type: Article

References (45)

1. Cormode DP, Skajaa T, Fayad ZA, Mulder WJ: Nanotechnology in medical imaging: probe design and applications. Arterioscler. Thromb. Vasc. Biol. 29(7), 992-1000 (2009).
2. Amirbekian V, Lipinski MJ, Briley-Saebo KC et al.: Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl Acad. Sci. USA 104(3), 961-966 (2007).
3. Briley-Saebo KC, Shaw PX, Mulder WJ et al.: Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specifc epitopes. Circulation 117(25), 3206-3215 (2008).
4. Chen W, Vucic E, Leupold E et al.: Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast Media Mol. Imaging 3(6), 233-242 (2008).
5. Frias JC, Williams KJ, Fisher EA, Fayad ZA: Recombinant HDL-like nanoparticles: a specifc contrast agent for MRI of atherosclerotic plaques. Am. Chem. Soc. 126(50), 16316-16317 (2004).
6. Bruns OT, Ittrich H, Peldschus K et al.: Real-time magnetic resonance imaging and quantifcation of lipoprotein metabolism in vivo using nanocrystals. Nat. Nanotechnol. 4(3), 193-201 (2009).
7. Peters D, Kastantin M, Kotamraju VR et al.: Targeting atherosclerosis by using modular, multifunctional micelles. Proc. Natl Acad. Sci. USA 106(24), 9815-9819 (2009).
8. Ravichandran KS, Lorenz U: Engulfment of apoptotic cells: signals for a good meal. Nat. Rev. Immunol. 7(12), 964-974 (2007).
9. Greenberg ME, Li XM, Gugiu BG et al.: The lipid whisker model of the structure of oxidized cell membranes. Biol. Chem. 283(4), 2385-2396 (2008).
10. Huynh Ml, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of infammation. Clin. Invest. 109(1), 41-50 (2002).
11. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum Jl: Beyond cholesterol. Modifcations of low-density lipoprotein that increase its atherogenicity. N. Engl. Med. 320(14), 915-924 (1989).
12. Fossheim Sl, Fahlvik AK, Klaveness J, Muller RN: Paramagnetic liposomes as MRI contrast agents: infuence of liposomal physicochemical properties on the in vitro relaxivity. Magn. Reson. Imaging 17(1), 83-89 (1999).
13. Kritharides L, Jessup W, Gifford J, Dean RT: A method for defning the stages of low-density lipoprotein oxidation by the separation of cholesterol-and cholesteryl ester-oxidation products using HPLC. Anal. Biochem. 213(1), 79-89 (1993).
14. Campos SM, Penson RT, Mays AR et al.: The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. Gynecol. Oncol. 81(2), 206-212 (2001).
15. Al-Batran SE, Bischoff J, Von Minckwitz G et al.: The clinical beneft of PEGylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre Phase II trial. Br. Cancer 94(11), 1615-1620 (2006).
16. Parac-Vogt TN, Kimpe K, Laurent S et al.: Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging. Eur. Biophys. J. 35(2), 136-144 (2006).
17. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Clin. Invest. 34(9), 1345-1353 (1955).
18. Rajagopalan S, Duquaine D, King S, Pitt B, Patel P: Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 105(18), 2212-2216 (2002).
19. Sirol M, Itskovich V V, Mani V et al.: Lipid-rich atherosclerotic plaques detected by gadofuorine-enhanced in vivo magnetic resonance imaging. Circulation 109(23), 2890-2896 (2004).
20. Hyafl F, Laissy JP, Mazighi M et al.: Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infltration. Arterioscler. Thromb. Vasc. Biol. 26(1), 176-181 (2006).
21. Montembault V, Soutif JC, Brosse JC: Synthesis of chelating molecules as agents for magnetic resonance imaging. 3. Polycondensation of diethylenetriaminepentaacetic acid bisanhydride with diols and diamines. React. Funct. Polym. 29(1), 29-39 (1996).
22. Papahadjopoulos D, Watkins JC: Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. Biochim. Biophys. Acta 135(4), 639-652 (1967).
23. Forte TM, Carlson LA: Electron microscopic structure of serum lipoproteins from patients with fsh eye disease. Arteriosclerosis 4(2), 130-137 (1984).
24. Martin T W, Joist JH, Bauman JE, Lagunoff D: Activation of human platelets by N-substituted aminophospholipids. Biol. Chem. 260(5), 2852-2856 (1985).
25. Mustard JF, Medway W, Downie HG, Rowsell HC: Effects of intravenous phospholipid containing phosphatidyl serine on blood clotting with particular reference to the Russell's viper venom time. Nature 196, 1063-1065 (1962).
26. Brunauer LS, Huestis WH: Effects of exogenous phospholipids on platelet activation. Biochim. Biophys. Acta 1152(1), 109-118 (1993).
27. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl Acad. Sci. USA 76(1), 333-337 (1979).
28. Libby P: Infammation in atherosclerosis. Nature 420(6917), 868-874 (2002).
29. Ramos GC, Fernandes D, Charao CT, Souza DG, Teixeira MM, Assreuy J: Apoptotic mimicry: phosphatidylserine liposomes reduce infammation through activation of peroxisome proliferator-activated receptors (PPARS) in vivo. Br. Pharmacol. 151(6), 844-850 (2007).
30. Jaffer Fa, Libby P, Weissleder R: Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29(7), 1017-1024 (2009).
31. Kobayashi K, Matsuura E, Liu Q et al.: A specifc ligand for b(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. Lipid Res. 42(5), 697-709 (2001).
32. Liu Q, Kobayashi K, Furukawa J et al.: Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for b(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages. Lipid Res. 43(9), 1486-1495 (2002).
33. Chnari E, Lari HB, Tian L, Uhrich KE, Moghe PV: Nanoscale anionic macromolecules for selective retention of low-density lipoproteins. Biomaterials 26(17), 3749-3758 (2005).
34. Greenspan P, Ryu BH, Mao F, Gutman RL: Association of negatively-charged phospholipids with low-density lipoprotein (LDL) increases its uptake and the deposition of cholesteryl esters by macrophages. Biochim. Biophys. Acta 1257(3), 257-264 (1995).
35. Hanayama R, Tanaka M, Miyasaka K et al.: Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-defcient mice. Science 304(5674), 1147-1150 (2004).
36. Yamada N, Shimano H, Mokuno H et al.: Increased clearance of plasma cholesterol after injection of apolipoprotein E into watanabe heritable hyperlipidemic rabbits. Proc. Natl Acad. Sci. USA 86(2), 665-669 (1989).
37. Blanco FJ, Villegas S, Benitez S et al.: 2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles. Lipid Res. 51(6), 1560-1565 (2010).
38. Ling W, Lougheed M, Suzuki H, Buchan A, Kodama T, Steinbrecher UP: Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class a type I/II gene. Clin. Invest. 100(2), 244-252 (1997).
39. Nagelkerke JF, Barto KP, Van Berkel TJ: In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, kupffer, and parenchymal cells. Biol. Chem. 258(20), 12221-12227 (1983).
40. 131I]-sodium iodide. Br. Pharmacol. 67(3), 459P (1979).
41. Briley-Saebo KC, Mulder WJ, Mani V et al.: Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. Magn. Reson. Imaging 26(3), 460-479 (2007).
42. Reulen SW, Brusselaars WW, Langereis S, Mulder WJ, Breurken M, Merkx M: Protein-liposome conjugates using cysteine-lipids and native chemical ligation. Bioconjug. Chem. 18(2), 590-596 (2007).
43. Brandwijk RJ, Mulder WJ, Nicolay K, Mayo KH, Thijssen Vl, Griffoen AW: Anginex-conjugated liposomes for targeting of angiogenic endothelial cells. Bioconjug. Chem. 18(3), 785-790 (2007).
44. Wickline SA, Neubauer AM, Winter PM, Caruthers SD, Lanza GM: Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. Magn. Reson. Imaging 25(4), 667-680 (2007).
45. 3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett. 10(1), 52-58 (2010).